Triomics nabs $22M to bring true oncology AI to the cancer space

Triomicsa startup building an AI-powered platform to help oncologists and staff streamline workloads such as clinical trial matching and planning, has raised $22 million in Series B funding.

The round was led by Battery Ventures, with participation from backers Nexus Venture Partners, Lightspeed, Y Combinator, and others.

The good news is that advances in oncology are helping patients live longer. This accepted practice, however, is creating years of medical records that take a long time for health care professionals to review and interpret.

A typical medical chart includes medical records, comparisons and disease reports, as well as fax scans. “We’ve seen medical records (with) thousands of pages,” Triomics co-founder Sarim Khan told TechCrunch.

Launched in 2021, the startup raised a $15 million in Series A in 2024. Initially focused on helping doctors identify the right clinical trials for their patients, Triomics expanded its platform as LLM’s capabilities grew. Over the past few years, Triomics has added patient summaries to its platform, displaying key information within the tools doctors already use, without requiring them to change software.

By reducing preparation time, these briefs give oncologists more time with their patients. Good access requires more than individual selection: in oncology, where patient profiles are very complex and staff stress is a constant problem, tools that reduce the administrative burden have great potential.

Triomics is also used to streamline the tedious task of reporting tumors to government registries, the official responsibility of cancer centers.

While generic AI assistants win in the short term, well-known institutions such as Memorial Sloan Kettering (MSK) and the Yale Cancer Center use Triomics because its models are specifically trained in oncology, Khan explained.

Triomics’ direct competition comes from AI medical scribes such as Abridge and Microsoft Nuance — tools that use AI to listen to and record patient-doctor conversations — when it comes to summarizing patient charts.

Despite fierce competition, Triomics is growing rapidly. According to Khan, the startup has quadrupled its customer base over the past year, resulting in a 10-fold increase in annual recurring revenue.

Pictured left to right: Sarim Khan, Triomics co-founder and CEOand Hrituraj SinghTriomics co-founder and CTO.